| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | +3.21% | -0.84% | +4.05% | +4.10% | — |
| 14d | 4 | +25.00% | +12.94% | +0.40% | +12.54% | +12.41% | — |
| 30d | 4 | +50.00% | +10.98% | +1.19% | +9.79% | +12.66% | — |
| 60d | 4 | +50.00% | +9.22% | -0.26% | +9.48% | +8.03% | — |
| 90d | 4 | +100.00% | -8.62% | -4.25% | -4.37% | -12.16% | — |
| 180d | 4(1 pending) | +100.00% | -22.70% | +10.08% | -32.78% | -37.65% | — |
| 1y | 4(1 pending) | +66.67% | -60.24% | +22.25% | -82.48% | -76.62% | — |
| 2y | 4(3 pending) | +0.00% | -79.79% | +16.64% | -96.43% | -96.43% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,591 | $6.82 | $72.2K | 121,220 | Jan 6, 2026 | Jan 8, 2026 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 37,000 | — | — | 131,811 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 109,000 | — | — | 109,000 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Financial Officer | 4,028 | $16.83 | $67.8K | 94,811 | Jan 6, 2025 | Jan 7, 2025 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Financial Officer | 3,961 | $16.72 | $66.2K | 98,839 | Jan 3, 2025 | Jan 7, 2025 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 22,000 | — | — | 102,800 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 64,600 | — | — | 64,600 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,424,000 | — | — | 2,424,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,110,000 | — | — | 3,110,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,250,000 | $0.79 | $987.5K | 0 | Nov 13, 2023 | Nov 15, 2023 ↗ | View → |
| TARA PROTARA THERAPEUTICS, INC. | SALE Chief Financial Officer | 5,081 | $3.13 | $15.9K | 20,662 | Jul 15, 2022 | Jul 19, 2022 ↗ | View → |
| TARA PROTARA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 14,100 | — | — | 15,581 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| TARA PROTARA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 84,800 | — | — | 84,800 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| TARA PROTARA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Jan 19, 2021 | Jan 21, 2021 ↗ | View → |
| TARA PROTARA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 1,481 | $16.91 | $25.0K | 1,481 | Sep 22, 2020 | Sep 22, 2020 ↗ | View → |
| TARA PROTARA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 94,000 | — | — | 94,000 | Feb 11, 2020 | Feb 11, 2020 ↗ | View → |